CN Patent

CN119424386B — 含有芦可替尼的外用速溶膜及其制备方法和应用

Assigned to Shenzhen Taili Biomedical Co ltd · Expires 2025-07-25 · 1y expired

What this patent protects

本发明公开了一种含芦可替尼的外用速溶膜及其制备方法和应用，该外用速溶膜原料包括重量份比为1：5~20的磷酸芦可替尼或其药学上可接受的盐和成膜剂，所述成膜剂为聚环氧乙烯或聚乙烯醇。本发明的外用速溶膜具有载药量高、溶出速率快、药物累计释放量高、渗透速率高的优点，其与皮肤粘合程度好，不易弄脏衣物，相比于乳膏剂或其他外用剂型，顺应性更好。

USPTO Abstract

本发明公开了一种含芦可替尼的外用速溶膜及其制备方法和应用，该外用速溶膜原料包括重量份比为1：5~20的磷酸芦可替尼或其药学上可接受的盐和成膜剂，所述成膜剂为聚环氧乙烯或聚乙烯醇。本发明的外用速溶膜具有载药量高、溶出速率快、药物累计释放量高、渗透速率高的优点，其与皮肤粘合程度好，不易弄脏衣物，相比于乳膏剂或其他外用剂型，顺应性更好。

Drugs covered by this patent

Patent Metadata

Patent number
CN119424386B
Jurisdiction
CN
Classification
—
Expires
2025-07-25
Drug substance claim
No
Drug product claim
No
Assignee
Shenzhen Taili Biomedical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.